News

According to the European Union Drugs Agency 2025 report, France has the highest lifetime cannabis usage rate among adults in the EU. Over 50% of French adults report having used cannabis at least once, compared to 43.7% in Spain and 37.6% in Denmark. When considering recent use, 10.8% of adults in France consumed cannabis in the past year, placing the country just behind Spain (12.6%). Approximately 6.8% of adults reported usage within the past month, highlighting a sizable and active consumer base. Untapped Market Potential With a population of 68.5 million, France has a massive cannabis audience. Yet 99.7% of the...

Understanding Pancreatitis The pancreas is a vital gland located behind the stomach, playing two essential biological roles: Producing insulin to regulate blood sugar Producing digestive enzymes that help the body break down food When the pancreas becomes inflamed, the condition is known as pancreatitis. In cases of chronic pancreatitis (CP), the inflammation is ongoing and often debilitating. Treatments can include strict diets, enzyme supplements, pain management with medications, and in severe cases, surgical procedures such as a total pancreatectomy. A November 2024 study highlighted the scale of the problem: between 1990 and 2021, global cases of pancreatitis increased by nearly...

All plants—from fruits and grains to vegetables and herbs—produce phytochemicals, compounds responsible for flavor, aroma, and color, as well as for protecting the plant against pathogens. Cannabis is no exception. In fact, its phytochemical complexity is one of the reasons why it shows such therapeutic promise. For patients, understanding these compounds is essential: they influence not only efficacy and safety, but also how different cannabis strains may be used for specific medical conditions. A Groundbreaking Collaboration in Brazil In an effort to push cannabis science forward, several of Brazil’s top universities have joined forces to create a national phytochemical database...

Every legal medical cannabis market worldwide requires strict quality controls before products can reach patients. For the European Union, the benchmark is Good Manufacturing Practice (GMP) compliance—arguably the highest global standard for medical cannabis. Products entering EU markets, especially Germany’s thriving medical cannabis sector, must demonstrate that they: Are of consistently high quality Are appropriate for their intended medical use Meet all conditions of their marketing or clinical trial authorization These requirements are defined by the European Medicines Agency (EMA) and enforced across member states. Decontamination: The Core of GMP Compliance One of the most critical aspects of GMP cannabis...